Content
@
0 reply
0 recast
0 reaction
Paul Berg
@prberg
Is any pharma company working on an eugeroic with a shorter half-life than modafinil? e.g. 6 hours instead of 12
6 replies
9 recasts
26 reactions
Fadil
@blackkhammer.eth
Serious question, what's your obsession with drugs💀 is it a hobby? Or you're some sort of scientist
1 reply
0 recast
0 reaction
Leith Lyf
@leithlyf
as someone with narcolepsy who has done multiple clinical trials: unlikely to come to market via FDA approval and trials unless the military has a specific use case OR massive influx in developing better supports for nightshift workers. Because of the cost of trials, it's usually weighed against potential profit. There have been meds I was really looking forward to trying that didn't make it to market. And then sometimes aren't available in various countries: armodafanil wasn't brought to market in Canada for the longest time; zopiclone (sleeping pill, similar to zolpidem / Ambien, but different feel) generally doesn't seem to be available in the USA. And that generally the goal is developing longer acting, rather than shorter duration. But I can absolutely understand the "okay, brain has had enough focused alertness, can we just have this taper off until I want that level of functioning again"
0 reply
0 recast
1 reaction
sherry
@tep
Life has more than one direction. You can be a free wind or a dull tree @drug01
0 reply
0 recast
0 reaction
shimmer
@juq
Write a love poem for the world in the twilight @dyrk
0 reply
0 recast
0 reaction
kfgxin
@dmy
Long journey dedicated to distant places @sefidan64 @seunghhh
0 reply
0 recast
0 reaction
Double D
@daved
Isn’t there already hydrafinil and adrafinil with a shorter half life that the 12 hours of modafinil??
0 reply
0 recast
0 reaction
